Surrogate endpoints in breast cancer screening trials

Producción científica: Letter › revisión exhaustiva

ASJC Scopus subject areas

@article{9c34d51ecc6b48238f269726eebf79a8,

title = "Surrogate endpoints in breast cancer screening trials",

author = "Ismail Jatoi",

year = "2022",

month = aug,

doi = "10.1016/S1470-2045(22)00370-9",

language = "English (US)",

volume = "23",

pages = "e360",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd",

number = "8",

}

TY - JOUR

T1 - Surrogate endpoints in breast cancer screening trials

AU - Jatoi, Ismail

PY - 2022/8

Y1 - 2022/8

UR - http://www.scopus.com/inward/record.url?scp=85134824829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85134824829&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(22)00370-9

DO - 10.1016/S1470-2045(22)00370-9

M3 - Letter

C2 - 35901822

AN - SCOPUS:85134824829

SN - 1470-2045

VL - 23

SP - e360

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 8

ER -